MedCity Investor Showcase

Since the programme’s inception in 2014, it has focused on creating links between Business Angels and early stage investment opportunities. The main identified verticals being healthcare and life science companies

The latest event was hosted by FieldFisher, a world renowned Law Firm with global outreach spanning 24 office locations. FieldFisher’s London HQ provided the dramatic skyline backdrop for 5 start-ups to pitch their visions to a room of 80 Angels offering a £7.9m opportunity. The companies pitching were:

  • Medicspot, creating networks of clinical examination stations to quell the ever increasing appointment demands.
  • OR Productivity, pioneering their FreeHand Robot to provide stable video solutions for keyhole surgeries, a previous venture for NPI in the 2012 and 2014 EIS/SEIS funds.
  • SurgEase, creating a modern solution for diagnosis of rectal cancer to identify legions earlier thereby potential life expectancy.
  • Eagle Genomics, developing a platform for looking into data analysis of Microbiomics, another previous venture for NPI in the 2013,2016 and 2017 (SUF 1) EIS/SEIS Funds.
  • OMS, offering an alternative medical training method for medical professionals using VR technologies.

Following the success of the event prospective Angels have made contact and liaised with the business, through NPI. These deals are still in progress but our KPIs indicate the programme continues to prove invaluable to both NPI and MedCity with many more events slated for 2019.

Newable Ventures Limited (FRN 795277) is an Appointed Representative of Larpent Newton & Co Ltd. Larpent Newton & Co Ltd is authorised and regulated by the Financial Conduct Authority, FRN 141275.
Neither Newable Capital Limited nor Newable Private Investing Limited are Authorised and Regulated by the Financial Conduct Authority. Risk warning: Your capital is at risk. Investing in early stage companies involves risks including loss of capital, illiquidity, lack of dividends and dilution.
Newable Ventures Limited does not give tax or investment advice.
The availability of tax relief depends on individual investors’ circumstances, and on investee companies’ qualifying status, both of which may be subject to change. If you are in doubt about eligibility for tax reliefs or the tax treatment of your investment, you should seek independent tax advice.